Dogan, Sait MuratKutluturk, Koray2024-08-042024-08-0420201941-66281941-6636https://doi.org/10.1007/s12029-020-00481-1https://hdl.handle.net/11616/99480Introduction Liver transplantation is the definitive treatment modality of the patients having an end-stage liver disease with hepatocellular carcinoma. Discussion The number of living donor liver transplantations has been increased because of the deceased donor organ shortage, especially in Asian countries. Conclusion Reports of different clinics about the postoperative course and tumor recurrence rates comparing living donor versus deceased donor liver transplantations, besides patient selection criteria, are reviewed along with our clinic's experiences.eninfo:eu-repo/semantics/closedAccessHepatocellular carcinomaLiving donor liver transplantationDeceased donor liver transplantationReview Article514110411063283322110.1007/s12029-020-00481-12-s2.0-85089781669Q3WOS:000562325600003N/A